本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Blueprint Medicines Corporation

129.46
0.0000
成交量:- -
成交额:3.85亿
市值:83.80亿
市盈率:-52.77
高:129.46
开:129.46
低:129.46
收:129.46
52周最高:129.65
52周最低:73.04
股本:6,473.36万
流通股本:6,014.42万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.4532
每股收益(LYR):-1.0673
净资产收益率:-47.71%
总资产收益率:-9.75%
市净率:24.49
市盈率(LYR):-121.29

数据加载中...

2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/25

重要事件披露

Form 8-K - Current report
2024/03/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities